Login

Jesper Wiklund, CEO, Klaria Pharma Holding AB (publ) 00:00:00

Share On Facebook Share On Twitter

Klaria Pharma Holding AB (publ)

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Far Point Acquisition Acquires Global Blue for $2.6 Billion | Thomas W. Farley - Independent Chairman of Global Blue Group Holding Ltd
00:10:00
Gust Kepler of BlackBoxStocks on the Rise of Retail Investors and Wall Street's David vs Goliath Battle | Gust Kepler, CEO, BlackBoxStocks Inc.
00:10:00
Loves to invest in scrappy founders somewhat bootstrap mentality|Elizabeth Yin,General Partner,Hustle Fund
00:10:00
Identify and evaluate investment opportunities|Amy Duffuor,Managing Director,Prime Impact Fund
00:10:00
Empowering Communities: Lincoln Financial Foundation and Bunker Labs Initiatives
00:10:00
creating something of true significance starts with seeing things|Morgan Beller,General Partner,NFX
00:10:00
Balancing Success: Insights from Todd Brand
00:10:00
Global Investment Powerhouse: Building Success Across Industries and Economies | Bruce Flatt, CEO,Brookfield Asset Management.
00:10:00
Hartford CEO Christopher J. Swifton Economic Outlook, Inflation, and California's Regulatory Challenges | Christopher J. Swift, CEO , The Hartford.
00:10:00
Beneficiary of the Belt and Road Initiative: RC Mines' Strategic Iron Ore Projects
00:10:00
2019 Investing Opportunities in Fixed Income | Rick Genoni and Ellen Cammer Discuss Strategies
00:10:00
Frontier Diamonds: Paving the Way for Growth and Expansion

© 2026 Nehu